FDA Inspection 1157721 — Centaur Inc
The FDA completed an inspection of Centaur Inc on November 11, 2021 in Olathe, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 11, 2021
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Olathe, KS (United States)